VanEck Pharmaceutical ETF
133 hedge funds and large institutions have $530M invested in VanEck Pharmaceutical ETF in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 49 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
24% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 25
29% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 49
97% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $64.7M
Holders
133
Holding in Top 10
1
Calls
$1.67M
Puts
$64.7M
Top Buyers
| 1 | +$117M | |
| 2 | +$18.7M | |
| 3 | +$11.6M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.28M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$4.56M |
Top Sellers
| 1 | -$103M | |
| 2 | -$17.3M | |
| 3 | -$13.2M | |
| 4 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$12M |
| 5 |
Two Sigma Investments
New York
|
-$8.58M |